Skip to content

Oral Intake Of Pashanbhed Churna In The Management Of Mutrakruchchra

Open randomized control clinical trial of pashanbhed churna in mutrakruchchra - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077358
Enrollment
84
Registered
2024-11-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

None listed

Sponsors

Dr Vaibhav Rajendra Dongare
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient showing maximum classical sign symptoms of Mutrakruchchra described As Follow: a. Sadah mutrapravrutti b. Saruja mutrapravrutti c. Muhur-muhur Mutrapravrutti

Exclusion criteria

Exclusion criteria: 1. Urinary Tract Infection associated with Calculus which need surgical intervention. 2. Patient having Malignancy, Uncontrolled Diabetes mellitus , BPH and Traumatic causes. 3. Pregnant women and lactating mother. 4. Neurological diseases causing Urinary Retention, presence of foreign bodies such as And welling catheters other drainage devices. 5. Chronic kidney disease, Renal failure, renal transplant patient Will be excluded

Design outcomes

Primary

MeasureTime frame
To Evaluate The Efficacy Of Pashanbhed Churna On Mutrakruchchra.Timepoint: 7 Days

Secondary

MeasureTime frame
1To Study Literature Of Mutrakruchchra. 2To Access Properties,Positive Effects and Untoward Effect Of Pashanbhed Churna On Mutrakruchchra. 3 To Study Detailed About Mutrakruchchra Timepoint: 7 Days

Countries

India

Contacts

Public ContactDr Manoj Patil

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Center Ashta

dr.patilmanoj77@gmail.com9422613195

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026